ADAP

Adaptimmune Therapeutics

45 hedge funds and large institutions have $380M invested in Adaptimmune Therapeutics in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
45
Holders Change
+45
Holders Change %
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
45
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
ACP
26
Acuta Capital Partners
California
$550K 30,000 +30,000 New
FAM
27
Fred Alger Management
New York
$521K 28,445 +28,445 New
TCM
28
Tekla Capital Management
Massachusetts
$504K 27,500 +27,500 New
CAM
29
Cormorant Asset Management
Massachusetts
$458K 25,000 +25,000 New
BG
30
BlackRock Group
United Kingdom
$452K 24,665 +24,665 New
State of New Jersey Common Pension Fund D
31
State of New Jersey Common Pension Fund D
New Jersey
$440K 24,000 +24,000 New
RI
32
RTW Investments
New York
$367K 20,000 +20,000 New
PIM
33
Partner Investment Management
California
$333K 18,194 +18,194 New
NSEDCP
34
NJ State Employees Deferred Compensation Plan
New Jersey
$293K 16,000 +16,000 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$279K 15,232 +15,232 New
VKH
36
Virtu KCG Holdings
New York
$273K 14,904 +14,904 New
CC
37
CQS Cayman
Cayman Islands
$231K 12,558 +12,558 New
Morgan Stanley
38
Morgan Stanley
New York
$211K 11,517 +11,517 New
BIT
39
BlackRock Institutional Trust
California
$95K 5,165 +5,165 New
UBS Group
40
UBS Group
Switzerland
$40K 2,155 +2,155 New
GT
41
Glenmede Trust
Pennsylvania
$33K 1,825 +1,825 New
OAJ
42
Ogorek Anthony Joseph
New York
$18K 1,000 +1,000 New
AH
43
Achievement Holdings
Illinois
$4.19K 228,644 +228,644 New
Bank of America
44
Bank of America
North Carolina
$4K 200 +200 New
BlackRock
45
BlackRock
New York
$3K 170 +170 New